My Companies
Notification
Account
Log Out
Login
US FDA classified 17-21 Aug 2026 inspection of step-down subsidiary Lannett's Seymour, Indiana facility as OAI after four observations; company cites no financial/operational impact.
Aurobindo Pharma Unit I Receives US FDA Warning Letter
Aurobindo Pharma Gets FTC Approval for Lannett Acquisition, Closing This Month
Aurobindo Pharma's Unit-III Gets FDA OAI After 11 Inspection Observations